Chicago, ILNCT04715139Now EnrollingIRB Ready

Hyperpronated Foot Clinical Trial in Chicago, IL

Access cutting-edge hyperpronated foot treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.

Sponsored by Arthrex, Inc.

Quick Self-Assessment

See if you qualify for this Chicago location

Preparing your pre-screening questions…

Expert Care in Chicago

Access hyperpronated foot specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hyperpronated foot treatment provided free

Apply for This Chicago Location

Check if you qualify for this hyperpronated foot clinical trial in Chicago, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chicago

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chicago site if eligible
  4. 4Begin participation

About This Hyperpronated Foot Study in Chicago

The objective of the registry is to evaluate the continued safety and performance of Arthrex foot and ankle products, including the ProStop® implant for hyperpronated foot; Bio-Compression Screw for reconstruction surgeries of the foot; TRIM-IT Drill Pin® system and/or TRIM-IT Spin Pin™ system for fixation of fractures and fusion (bunionectomy osteotomies) of the foot/ankle; Headless Compression Screws and Compression FT Screws for fixation of small bone fragments of the foot/ankle; DynaNite® nitinol staple for midfoot and hindfoot arthrodeses or osteotomies, first metatarsophalangeal arthrodesis, and mono or bi-cortical osteotomies in the forefoot; BioComposite SutureTak® anchor for medial ankle stabilization; Beveled FT Screws for hallux valgus repair; KreuLock™ screws for ankle fractures; ArthroFLEX® dermal allograft for hallux rigidus arthroplasty; and DualCompression Hindfoot Nail for tibiotalocalcaneal arthrodesis.

Sponsor: Arthrex, Inc.

Who Can Participate

Inclusion Criteria

Subject requires surgery using Arthrex foot and ankle products included in the registry.
Subject is 18 years of age or over (all products except ProStop®).
Subject age \>two to 17 years (ProStop® product only).
Capable of completing self-administered questionnaires.
Willing and able to return for all study-related follow-up visits.
Subject or subject's representative signed informed consent and assent, when applicable, and is willing and able to comply with all study requirements. (ArthroFLEX® subjects only):
Degenerative or post-traumatic arthritis of the 1st MTP joint with grade 2, 3, or 4.
Subjects who require surgical intervention or are medically indicated for an arthrodesis or arthroplasty of the 1st MTP. DualCompression Hindfoot Nail subjects only:
The participant must have instability, arthritis, rigid deformity, or severe foot or ankle deformity necessitating tibiotalocalcaneal arthrodesis, commonly referred to as TTC arthrodesis.
The participant should be undergoing treatment with the Arthrex DualCompression Hindfoot Nail, either as a primary procedure or as a revision surgery, per standard of care

Exclusion Criteria

Insufficient quantity or quality of bone.
Blood supply limitations and previous infections, which may retard healing.
Foreign-body sensitivity.
Any active infection or blood supply limitations.
Conditions that tend to limit the patient's ability or willingness to restrict activities or follow directions during the healing period.
Subjects that are skeletally immature (except for ProStop®).
Subject is considered from vulnerable population (i.e., child, prisoner, pregnant).
Subjects who are contraindicated for these devices.
Subject is currently receiving compensation or benefits due to a work-related injury or illness under any applicable occupational injury or disability program.
Subject has a planned or scheduled additional surgery on the affected or contralateral lower extremity within the course of the study. (® Nitinol Staple Subjects only):
Subjects who have a comminuted bone surface that would not allow for staple placement as required by the DynaNite® Nitinol Staples directions for use.
Subjects who have pathologic bone conditions such as osteopenia that would impair the ability to securely fix the implant as required by the DynaNite® Nitinol Staples directions for use. (ArthroFLEX® subjects only):
Additional ipsilateral lower limb pathology that requires active treatment.
Bilateral degenerative or post-traumatic arthritis of the 1st MTP joints that would require simultaneous treatment of both MTP joints.
Diagnosis of gout.
Any significant bone loss, avascular necrosis, and/or large osteochondral cyst (\>1cm) of the 1st MTP joint.
Lesions greater than 10mm in size.
Hallux varus to any degree, or hallux valgus \>20 degrees. (DualCompression Hindfoot Nail subjects only):
Requiring only a tibiotalar or subtalar arthrodesis
Patient requires bulk allograft or metal spacer implant to fill large bony defect and aid in limb salvage

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chicago?

Yes, this clinical trial (NCT04715139) has an active research site in Chicago, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hyperpronated Foot Treatment Options in Chicago, IL

If you're searching for hyperpronated foot treatment options in Chicago, IL, this clinical trial (NCT04715139) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hyperpronated foot specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hyperpronated foot clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Chicago, IL

See all pulmonary embolism clinical trials recruiting in Chicago — not just this study.

Browse Pulmonary Embolism Trials in Chicago →

Browse More Trials by Condition

Pulmonary Embolism TrialsErectile Dysfunction TrialsRetinitis Pigmentosa TrialsAll Conditions →

Ready to Join in Chicago?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chicago, IL